In 2004, Sanofi-Synthélabo offered a takeover bid worth €47.8 billion for Aventis. After a number of deliberations, over a period of three months, Aventis agreed to an offer of €54.5 billion ...

Sanofi India Limited, was initially incorporated as Aventis Pharma Limited in May, 1956. The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.

Sanofi Chief Executive Paul Hudson has been in a tricky position. He needs to bolster his business to cope with a heavy reliance on eczema treatment Dupixent, which is expected to account for over ...

Send a tip to our reporters Site feedback: Take our Survey By Ashleigh Furlong May 30, 2025 at 3:14 AM EDT Updated on May 30, 2025 at 5:24 AM EDT Save ...

Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other ...

France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in rare immunology diseases, in the biggest deal struck by a European ...

In explaining its reasons for partnering on the project, in a launch announcement Thursday, Sanofi cited the results of a recent survey of 200 U.K. adults with Type 1 diabetes. Almost every ...

French pharmaceutical giant Sanofi is set to acquire U.S.-based Blueprint Medicines Corporation in a deal worth up to $9.5 billion, marking one of the largest European healthcare transactions of ...

Sanofi has been active in the M&A market this year, picking up Dren Bio’s clinical-stage bispecific antibody, DR-0201, for $600 million upfront and another $1.3 billion in milestones.

Sanofi SAN -0.11% agreed to buy Blueprint Medicines BPMC 0.06% for up to $9.5 billion, the French drugmaker’s biggest move yet to replenish its drug pipeline since it sold a controlling stake in ...

Sanofi shares on Euronext Paris, however, dipped 1.8% from €87.52 ($99.85) to €85.91 ($98.18). Hudson also said that Sanofi still retained a “sizeable” capacity for further acquisitions.